Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SSTR1 | P30872 | 1/20 | 0.49 |
| ▸ | SSTR2 | P30874 | 1/20 | 0.49 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.49 |
| ▸ | SSTR3 | P32745 | 1/20 | 0.49 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.33 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.33 |
| ▸ | TNF | P01375 | 1/20 | 0.33 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | HPSE | Q9Y251 | 2/20 | 0.31 |
| ▸ | CDC25B | P30305 | 1/20 | 0.31 |
| ▸ | TACR1 | P25103 | 1/20 | 0.31 |
| ▸ | FGF1 | P05230 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14632200 | 1.00 | SSTR1 (0.49) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7538441 | 0.94 | SSTR1 (0.47) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL5488121 | 0.88 | SSTR1 (0.53) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL14342168 | 0.88 | SSTR1 (0.53) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL24412885 | 0.83 | SSTR1 (0.35) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL19213283 | 0.82 | SSTR1 (0.36) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL14632135 | 0.81 | SSTR4 (0.58) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL7054827 | 0.80 | SSTR1 (0.48) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL15679614 | 0.79 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 | |
| SCHEMBL16770611 | 0.79 | SSTR1 (0.54) | SSTR1SSTR2SSTR4SSTR3SSTR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 193 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250332079-A1 | TOPICAL SUNSCREEN | CONCEPT MATRIX SOLUTIONS | 2025-10-30 | — | — | US | claimed |
| CN-120189355-A | Centella essence and production process thereof | 万亩良田生物医药科技(上海)有限公司 | 2025-06-24 | — | — | CN | claimed |
| EP-3174518-B1 | ANTIMICROBIAL FOAMING COMPOSITIONS CONTAINING CATIONIC ACTIVE INGREDIENTS | ECOLAB USA INC (US) | 2025-06-04 | — | — | EP | claimed |
| CN-119679678-A | Composition for eliminating aging cells and preparation method and application thereof | 陕西佰鸿合成生物科技有限公司 | 2025-03-25 | — | — | CN | claimed |
| CN-119345056-A | Instant red-dispelling composition, application thereof, cosmetic composition and preparation method thereof | 上海菲珂尔化妆品有限公司 | 2025-01-24 | — | — | CN | claimed |
| CN-115919770-A | Polygonatum polysaccharide liposome and preparation method thereof | 江苏农牧科技职业学院 | 2023-04-07 | — | — | CN | claimed |
| CN-110585047-B | Moisturizing repair liquid foundation and preparation method thereof | 广州品赫生物科技有限公司 | 2022-09-16 | — | — | CN | claimed |
| US-20260062843-A1 | MOIST WIPE | NICE PAK PROD INC (US) | 2026-03-05 | — | — | US | disclosed |
| US-12564579-B2 | Topical formulations of (1S)-1-phenyl-2-pyridin-2-ylethanamine | BIOHAVEN THERAPEUTICS LTD. (VG) | 2026-03-03 | — | — | US | disclosed |
| EP-4698227-A1 | SUPRAMOLECULAR ASSEMBLIES, COMPOSITIONS COMPRISING THE SAME AND METHODS FOR PRODUCING THE SAME | ELC Management LLC (US) | 2026-02-25 | — | — | EP | disclosed |
| EP-4687814-A1 | COSMETIC WATER-IN-OIL FORMULATIONS COMPRISING SODIUM POLYACRYLATE, XANTHAN GUM AND POTASSIUM CETYL PHOSPHATE | Coty Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| US-12508218-B2 | Coating compositions | COTY INC. (US) | 2025-12-30 | — | — | US | disclosed |
| US-12491166-B2 | Method of delivering an active compound and delivery device for use in the same | WACKER CHEMIE AG (DE) | 2025-12-09 | — | — | US | disclosed |
| CN-100391432-C | Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent | GALDERMA RES & DEV (FR) | 2008-06-04 | — | — | CN | disclosed |
| CN-1681473-A | Skin depigmenting compositions comprising adapalene and at least one depigmenting active agent | GALDERMA RES & DEV (FR) | 2005-10-12 | — | — | CN | disclosed |
| CN-1671759-A | Copolymers and their use in personal care compositions | CIBA SC HOLDING AG (CH) | 2005-09-21 | — | — | CN | disclosed |
| CN-1525848-A | Folic acid containing personal care products and uses thereof | 高斯米特公开有限公司 | 2004-09-01 | — | — | CN | disclosed |
| CN-1307469-A | Method of conditioning hair | PROCTER & GAMBLE (US) | 2001-08-08 | — | — | CN | disclosed |
| US-5059443-A | Dietetics | THE PROCTER & GAMBLE CO. (US) | 1991-10-22 | — | — | US | disclosed |
| EP-0415636-A2 | Esterified alkoxylated alkyl glycosides useful in low calorie fat-containing food compositions | THE PROCTER & GAMBLE COMPANY (US) | 1991-03-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12491166-B2 | Method of delivering an active compound and delivery device for use in the same | MMP8, CLPP, MMP7 | SSTR1 2054/4885SSTR2 2148/4885SSTR4 1900/4885 |
| US-20250332079-A1 | TOPICAL SUNSCREEN | SUN2, CYP51A1, DSG1 | SSTR1 4690/4885SSTR2 4619/4885SSTR4 4791/4885 |
| US-12564579-B2 | Topical formulations of (1S)-1-phenyl-2-pyridin-2-ylethanamine | CERS2, CNR2, FAAH2 | SSTR1 811/4885SSTR2 607/4885SSTR4 2410/4885 |
| US-20260062843-A1 | MOIST WIPE | IL36G, ORAI1, CUTA | SSTR1 598/4885SSTR2 535/4885SSTR4 1240/4885 |
| US-12508218-B2 | Coating compositions | TAS2R40, TAS2R20, TAS2R10 | SSTR1 970/4885SSTR2 1168/4885SSTR4 1152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.